Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT02443116 · COMPLETED
Trial details
- NCT number
- NCT02443116
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-31
- Primary completion
- 2019-12-06
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.